Comments
Loading...
Instil Bio (TIL) Forecast
NewsEarningsInstil Bio (TIL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInstil Bio (NASDAQ:TIL) Stock Quotes, Forecast and News Summary
Instil Bio Stock (NASDAQ: TIL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Instil Bio (TIL) stock?
You can purchase shares of Instil Bio (NASDAQ:TIL) through any online brokerage.
Who are Instil Bio (TIL) competitors?
Other companies in Instil Bio’s space includes: Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Instil Bio (TIL) stock?
Instil Bio has a consensus price target of $54.17.
What is the current price for Instil Bio (TIL)?
The stock price for Instil Bio (NASDAQ: TIL) is $22.58 last updated November 21, 2024 at 10:10 AM EST.
Does Instil Bio (TIL) pay a dividend?
There are no upcoming dividends for Instil Bio.
When is Instil Bio (NASDAQ:TIL) reporting earnings?
Instil Bio’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Instil Bio (TIL) going to split?
There is no upcoming split for Instil Bio.
What sector and industry does Instil Bio (TIL) operate in?
Instil Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.